{"id":"AGY-FED-HEALTH-OTHER-017","kind":"order","level":"federal","jurisdiction":"United States (federal); Drug Enforcement Administration, Diversion Control Division","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA","authority":"21 C.F.R. 1307.03; exception to 21 C.F.R. 1301.74(e) (signature on delivery of narcotics to NTPs)","instrument":"DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs","title":"DEA Dist/MNF narcotics shipments to OTP signed delivery exception (final)","dateIssued":"2020-04-10","effective":"2020-04-10 (digitally signed Apr. 11, 2020)","end":"For the duration of the public health emergency","startDate":"2020-04-10","endDate":"2021-09-30","quarters":["2020Q2","2020Q3","2020Q4","2021Q1","2021Q2","2021Q3"],"types":["SUPPLY","OTHER"],"addressees":["DEA-registered distributors","DEA-registered manufacturers"],"clause":"In order to allow NTP personnel the ability to comply with recommended basic protective measures and social distancing guidelines for the duration of this public health emergency, DEA is granting an exception to the provision of 21 CFR 1301.74(e) that requires a signature on delivery.","enforcement":"Registrant security requirements under 21 U.S.C. 823 and 842","functions":["SC supply chain","WH shipping and receiving","DR drivers (contactless delivery)"],"notes":"Pharmaceutical distributors changed delivery protocols nationwide.","sourceUrl":"https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-027)(DEA083)_DEA_Dist_MNF_narcotics_shipments_to_OTP_signed_delivery_exception_(final).pdf","snapshot":"https://web.archive.org/web/20200419025720/https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-027)(DEA083)_DEA_Dist_MNF_narcotics_shipments_to_OTP_signed_delivery_exception_(final).pdf","fileExists":true,"fileBytes":212492,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-017","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-017","citation":"William T. McDermott, Assistant Administrator, Diversion Control Division, DEA, DEA-DC-027 (DEA083), letter to DEA-registered distributors and manufacturers granting an exception to the signed-delivery requirement for narcotic shipments to narcotic treatment programs (Apr. 10, 2020) (Ex. AGY-FED-HEALTH-OTHER-017)","stateName":"","related":["AGY-FED-HEALTH-OTHER-018","AGY-FED-HEALTH-OTHER-019"]}